Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome

被引:4
|
作者
Kida, Elizabeth [1 ]
Walus, Marius [1 ]
Albertini, Giorgio [2 ,3 ]
Golabek, Adam A. [1 ]
机构
[1] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA
[2] IRCCS San Raffaele Pisana, Child Dev Dept, Rome, Italy
[3] IRCCS San Raffaele Pisana, Child Dev Dept, San Raffaele Cassino, Italy
关键词
Down syndrome; Ts65Dn mice; Wheel running; Excitation; inhibition; GFAP; Proteins; FIBRILLARY ACIDIC PROTEIN; ENVIRONMENTAL ENRICHMENT; HIPPOCAMPAL NEUROGENESIS; GLUTAMINE-SYNTHETASE; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; DENTATE GYRUS; RECEPTOR; EXERCISE; TRANSPORTER;
D O I
10.1016/j.brainres.2021.147535
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We showed previously that voluntary long-term running improved cognition and motor skills, but in an agedependent manner, in the Ts65Dn mouse model for Down syndrome (DS). Presently, we investigated the effect of running on the levels of some key proteins of the excitatory/inhibitory system, which is impaired in the trisomic brain, and on astroglia, a vital component of this system. Ts65Dn mice had free access to a running wheel for 9-13 months either from weaning or from the age of 7 months. Sedentary Ts65Dn mice served as controls. We found that running modified the levels of four of the seven proteins we tested that are associated with the glutamatergic/GABA-ergic system. Thus, Ts65Dn runners demonstrated increased levels of glutamine synthetase and metabotropic glutamate receptor 1 and decreased levels of glutamate transporter 1 and glutamic acid decarboxylase 65 (GAD65) versus sedentary mice, but of metabotropic glutamate receptor 1 and GAD65 only in the post-weaning cohort. GAD67, ionotropic N-methyl-D-aspartate type receptor subunit 1, and GABAA alpha 5 receptors' levels were similar in runners and sedentary animals. The number of glial fibrillary acidic protein (GFAP)-positive astrocytes and the levels of GFAP were significantly reduced in runners relative to sedentary mice. Our study provides new insight into the mechanisms underlying the beneficial effect of voluntary, sustained running on function of the trisomic brain by identifying the involvement of proteins associated with glutamatergic and GABAergic systems and reduction in reactive astrogliosis.
引用
收藏
页数:13
相关论文
共 44 条
  • [21] Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome
    Stagni, Fiorenza
    Raspanti, Alessandra
    Giacomini, Andrea
    Guidi, Sandra
    Emili, Marco
    Ciani, Elisabetta
    Giuliani, Alessandro
    Bighinati, Andrea
    Calza, Laura
    Magistretti, Jacopo
    Bartesaghi, Renata
    NEUROBIOLOGY OF DISEASE, 2017, 103 : 11 - 23
  • [22] Regional increase in brain accumulation of myo-inositol in Ts65Dn mouse (Down syndrome model)
    Shetty, HU
    Siarey, RJ
    Stoll, J
    Galdzicki, Z
    Rapoport, SI
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S30 - S30
  • [23] Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome
    Scott-McKean, Jonah J.
    Roque, Adriano L.
    Surewicz, Krystyna
    Johnson, Mark W.
    Surewicz, Witold K.
    Costa, Alberto C. S.
    NEURAL PLASTICITY, 2018, 2018
  • [24] Resolvin E1 Reduces Inflammation and Enhances Memory in the Ts65Dn Mouse Model of Down Syndrome
    Hamlett, E.
    Wang, X.
    Ledreux, A.
    Hjorth, E.
    Granholm, A. -C.
    Schultzberg, M.
    CELL TRANSPLANTATION, 2018, 27 (04) : 695 - 695
  • [25] Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome
    Kelley, Christy M.
    Ash, Jessica A.
    Powers, Brian E.
    Velazquez, Ramon
    Alldred, Melissa J.
    Ikonomovic, Milos D.
    Ginsberg, Stephen D.
    Strupp, Barbara J.
    Mufson, Elliott J.
    CURRENT ALZHEIMER RESEARCH, 2016, 13 (01) : 84 - 96
  • [26] Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model
    Choi, Jennifer H. K.
    Berger, Jason D.
    Mazzella, Matthew J.
    Morales-Corraliza, Jose
    Cataldo, Anne M.
    Nixon, Ralph A.
    Ginsberg, Stephen D.
    Levy, Efrat
    Mathews, Paul M.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (06) : 1818 - 1827
  • [27] Activation of phospholipase C and adenylyl cyclase signaling pathways in the Ts65Dn mouse brain, a model for Down syndrome
    Lumbreras, MA
    de Azza, IR
    Baamonde, C
    Martínez-Cui, C
    Dierssen, M
    Florez, J
    Sallis, J
    CYTOGENETICS AND CELL GENETICS, 1999, 86 (01): : 17 - 18
  • [28] Early postnatal GABAB antagonist treatment normalizes inhibitory/ excitatory balance in neonatal Ts65Dn mice, a genetic model of down syndrome
    Jin, Joshua
    Doan, James
    Fernandez, Cassandra
    Nguyen, Samuel
    Spencer, Cole
    Kleschevnikov, Alexander M.
    EXPERIMENTAL NEUROLOGY, 2025, 386
  • [29] Emergence of Treadmill Running Ability and Quantitative Assessment of Gait Dynamics in Young Ts65Dn Mice: A Mouse Model for Down Syndrome
    Scott-McKean, Jonah J.
    Jones, Ryan
    Johnson, Mark W.
    Mier, Joyce
    Basten, Ines A.
    Stasko, Melissa R.
    Costa, Alberto C. S.
    BRAIN SCIENCES, 2023, 13 (05)
  • [30] SHORT- AND LONG-TERM EFFECTS OF NEONATAL PHARMACOTHERAPY WITH EPIGALLOCATECHIN-3-GALLATE ON HIPPOCAMPAL DEVELOPMENT IN THE Ts65Dn MOUSE MODEL OF DOWN SYNDROME
    Stagni, Fiorenza
    Giacomini, Andrea
    Emili, Marco
    Trazzi, Stefania
    Guidi, Sandra
    Sassi, Martina
    Ciani, Elisabetta
    Rimondini, Roberto
    Bartesaghi, Renata
    NEUROSCIENCE, 2016, 333 : 277 - 301